Sharing Scientific Information with HCPs on Unapproved Uses of Medical Products: Dos and Don'ts Under FDA's New Draft Guidance | Epstein Becker & Green
In October 2023, the FDA released draft guidance entitled “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared...